Plos Negl Trop Dis Impact Factor

Advertisement

PLOS Negl Trop Dis Impact Factor: A Comprehensive Guide for Researchers



Introduction:

Are you a researcher grappling with the complexities of journal selection? Understanding the impact factor of a journal is crucial for maximizing the visibility and impact of your research. This comprehensive guide delves deep into the PLOS Neglected Tropical Diseases (PLOS NTD) impact factor, exploring its significance, trends, and implications for your publication strategy. We’ll unpack what the impact factor means, analyze its historical trajectory, and offer practical insights into why it matters and how it might influence your decision to submit your work to this esteemed journal. This post serves as a definitive resource for researchers aiming to understand the PLOS NTD impact factor and its role in the scholarly landscape.


1. Understanding the PLOS Neglected Tropical Diseases Journal

PLOS Neglected Tropical Diseases is an open-access, peer-reviewed scientific journal published by the Public Library of Science (PLOS). It focuses specifically on research related to neglected tropical diseases (NTDs), a group of infectious diseases that primarily affect impoverished populations in developing countries. These diseases often receive less attention and funding compared to other global health concerns, making the journal's mission of accelerating research and dissemination in this crucial area particularly important. The journal covers a broad spectrum of research, including epidemiology, diagnostics, treatment, prevention, and the social and economic impacts of NTDs.

2. What is the Impact Factor and Why Does it Matter?

The impact factor (IF) is a metric used to assess the relative importance of a journal within its field. It represents the average number of citations received by articles published in that journal during a specific period (typically the previous two years). A higher impact factor generally suggests that the journal publishes highly influential research that is frequently cited by other researchers. While the impact factor isn't a perfect measure of quality, it remains a significant benchmark for researchers, funders, and institutions evaluating the prestige and influence of a publication. Submitting to a high-impact factor journal can enhance the visibility of your work, potentially leading to increased citations, collaborations, and career advancement.

3. PLOS Neglected Tropical Diseases Impact Factor: A Historical Perspective

The PLOS NTD impact factor has fluctuated over the years, reflecting changes in the field of NTD research and the journal's own evolving editorial policies and scope. Tracking this historical trend provides valuable context for researchers considering submission. (Note: Precise historical impact factor data should be sourced directly from Journal Citation Reports (JCR) or the PLOS website, as these figures are subject to change). Analyzing past trends allows researchers to gauge the journal's relative standing compared to competitors and identify potential growth or decline in its influence. A downward trend might indicate a need for strategic re-evaluation, while a consistent upward trajectory demonstrates the journal's continued strength and appeal.

4. Factors Influencing the PLOS NTD Impact Factor

Several factors contribute to the PLOS NTD impact factor, including:

Quality of published research: Rigorous peer review processes and the publication of high-quality, impactful research are fundamental to a high impact factor.
Citation patterns: The frequency with which articles published in the journal are cited by other researchers directly influences the impact factor.
Journal visibility and accessibility: Open access publishing, robust online presence, and effective dissemination strategies contribute to increased visibility and citation rates.
Field-specific factors: Trends within the field of NTD research itself (e.g., breakthroughs in treatment, increased funding) can affect the overall citation rates of journals in the area.
Editorial policies: The journal's editorial policies regarding scope, article types, and peer review rigor play a vital role in shaping the quality and impact of published research.


5. Using the Impact Factor in Your Research Publication Strategy

The PLOS NTD impact factor, while important, should be considered within a broader context. Don't solely focus on maximizing the impact factor; prioritize the quality and relevance of your research to the field. Selecting a journal should be based on a careful assessment of several factors:

Relevance of the journal's scope to your research: Ensure your work aligns well with the journal's focus and target audience.
Journal's reputation and editorial standards: Consider the journal's reputation for quality peer review and its commitment to ethical publishing practices.
Accessibility and dissemination: Open-access journals like PLOS NTD offer broader dissemination of your research, potentially leading to a greater impact.
Audience reach: Consider the journal's readership and its potential to reach the relevant scientific community and stakeholders.


6. Beyond the Impact Factor: Other Metrics of Journal Quality

While the impact factor remains a widely used metric, it's essential to consider other measures of journal quality and influence, including:

CiteScore: This metric provides a broader view of citation patterns, incorporating citations from different sources and timeframes.
h-index: This metric considers both the number of citations and the number of papers cited.
Altmetric scores: These scores measure the attention and discussion generated by research articles across various online platforms, including social media and news outlets.


Article Outline: PLOS Neglected Tropical Diseases Impact Factor

Name: A Researcher's Guide to Maximizing Publication Impact in Neglected Tropical Disease Research

Outline:

Introduction: The importance of journal selection and the role of the impact factor.
Chapter 1: Understanding PLOS Neglected Tropical Diseases and its mission.
Chapter 2: A detailed explanation of the impact factor and its significance.
Chapter 3: Analysis of the historical trends of the PLOS NTD impact factor.
Chapter 4: Factors influencing the PLOS NTD impact factor and its implications for researchers.
Chapter 5: Strategic considerations for researchers when submitting to PLOS NTD or similar journals.
Chapter 6: Discussion of alternative metrics for evaluating journal quality beyond the impact factor.
Conclusion: A summary of key takeaways and recommendations for researchers.


(The detailed explanation of each chapter point would be provided in the expanded version of this article, following the structure outlined above. Each chapter would build upon the previous one, adding layers of complexity and detail to provide a complete and comprehensive guide.)


FAQs:

1. What is the current impact factor of PLOS Neglected Tropical Diseases? (Answer would require looking up the current data from JCR or PLOS.)
2. How is the PLOS NTD impact factor calculated? (Explanation of the calculation methodology)
3. Is the impact factor the only criterion for choosing a journal? (No, explain other factors)
4. How can I increase the chances of my research being published in PLOS NTD? (Guidance on writing strong manuscripts, etc.)
5. What are the benefits of publishing in an open-access journal like PLOS NTD? (Increased visibility, accessibility, etc.)
6. What are some alternative metrics to the impact factor that I should consider? (CiteScore, h-index, Altmetrics)
7. How does the PLOS NTD impact factor compare to other journals in the field of NTD research? (Comparative analysis with competitor journals)
8. Does a high impact factor guarantee a successful research career? (No, explain the limitations of impact factor)
9. What are some strategies for maximizing the citation rate of my published work in PLOS NTD? (Networking, promotion, etc.)


Related Articles:

1. The Impact of Open Access on Research Dissemination in NTDs: Discusses the advantages of open access in accelerating research progress.
2. Peer Review in PLOS NTD: A Critical Analysis: Evaluates the journal's peer review process and its impact on publication quality.
3. Metrics Beyond Impact Factor: Evaluating Journal Quality in Global Health: Explores alternative metrics for assessing journal quality.
4. Funding Opportunities for NTD Research: Provides a list of potential funding sources for NTD-related projects.
5. Collaboration in NTD Research: A Case Study: Highlights the importance of collaborative research in tackling NTDs.
6. The Social and Economic Impact of NTDs: Examines the broader societal consequences of these diseases.
7. Challenges in NTD Drug Development: Discusses the obstacles in creating new treatments for NTDs.
8. Global Health Equity and NTDs: Focuses on the ethical and social justice aspects of tackling NTDs.
9. The Role of Technology in NTD Surveillance: Explores the use of technology in monitoring and controlling the spread of NTDs.


This expanded structure provides a more comprehensive and SEO-optimized blog post that addresses the prompt's requirements. Remember to replace the bracketed information with actual data and expand on each point with sufficient detail and examples. Using relevant internal and external links will further enhance SEO.


  plos negl trop dis impact factor: Forgotten People, Forgotten Diseases Peter J. Hotez, 2020-07-24 Forgotten People, Forgotten Diseases Second Edition The neglected tropical diseases (NTDs) are the most common infections of the world's poor, but few people know about these diseases and why they are so important. This second edition of Forgotten People, Forgotten Diseases provides an overview of the NTDs and how they devastate the poor, essentially trapping them in a vicious cycle of extreme poverty by preventing them from working or attaining their full intellectual and cognitive development. Author Peter J. Hotez highlights a new opportunity to control and perhaps eliminate these ancient scourges, through alliances between nongovernmental development organizations and private-public partnerships to create a successful environment for mass drug administration and product development activities. Forgotten People, Forgotten Diseases also Addresses the myriad changes that have occurred in the field since the previous edition. Describes how NTDs have affected impoverished populations for centuries, changing world history. Considers the future impact of alliances between nongovernmental development organizations and private-public partnerships. Forgotten People, Forgotten Diseases is an essential resource for anyone seeking a roadmap to coordinate global advocacy and mobilization of resources to combat NTDs.
  plos negl trop dis impact factor: Investing to Overcome the Global Impact of Neglected Tropical Diseases World Health Organization, 2015-08-05 The presence, or absence, of neglected tropical diseases (NTDs) can be seen as a proxy for poverty and for the success of interventions aimed at reducing poverty. Today, coverage of the public-health interventions recommended by the World Health Organization (WHO) against NTDs may be interpreted as a proxy for universal health coverage and shared prosperity - in short, a proxy for coverage against neglect. As the world's focus shifts from development to sustainable development, from poverty eradication to shared prosperity, and from disease-specific goals to universal health coverage, control of NTDs will assume an important role towards the target of achieving universal health coverage, including individual financial risk protection. Success in overcoming NTDs is a litmus test for universal health coverage against NTDs in endemic countries. The first WHO report on NTDs (2010) set the scene by presenting the evidence for how these interventions had produced results. The second report (2013) assessed the progress made in deploying them and detailed the obstacles to their implementation. This third report analyses for the first time the investments needed to achieve the scale up of implementation required to achieve the targets of the WHO Roadmap on NTDs and universal coverage against NTDs. INVESTING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES presents an investment strategy for NTDs and analyses the specific investment case for prevention, control, elimination and eradication of 12 of the 17 NTDs. Such an analysis is justified following the adoption by the Sixty-sixth World Health Assembly in 2013 of resolution WHA6612 on neglected tropical diseases, which called for sufficient and predictable funding to achieve the Roadmap's targets and sustain control efforts. The report cautions, however, that it is wise investment and not investment alone that will yield success. The report registers progress and challenges and signals those that lie ahead. Climate change is expected to increase the spread of several vector-borne NTDs, notably dengue, transmission of which is directly influenced by temperature, rainfall, relative humidity and climate variability primarily through their effects on the vector. Investments in vector-borne diseases will avoid the potentially catastrophic expenditures associated with their control. The presence of NTDs will thereby signal an early warning system for climate-sensitive diseases. The ultimate goal is to deliver enhanced and equitable interventions to the most marginalized populations in the context of a changing public-health and investment landscape to ensure that all peoples affected by NTDs have an opportunity to lead healthier and wealthier lives.--Publisher's description.
  plos negl trop dis impact factor: Disease Control Priorities, Third Edition (Volume 6) King K. Holmes, Stefano Bertozzi, Barry R. Bloom, Prabhat Jha, 2017-11-06 Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.
  plos negl trop dis impact factor: Working to Overcome the Global Impact of Neglected Tropical Diseases World Health Organization. Department of Control of Neglected Tropical Diseases, World Health Organization, 2010 Neglected tropical diseases (NTDs) blight the lives of a billion people worldwide and threaten the health of millions more. These ancient companions of poverty weaken impoverished populations, frustrate the achievement of health in the Millennium Development Goals and impede global health and economies has convinced governments, donors, the pharmaceutical industry and other agencies, including nongovernmental organizations (NGOs), to invest in preventing and controlling this diverse group of diseases. Global efforts to control hidden diseases, such as dracunculiasis (guinea-worm disease), leprosy, gains including the imminent eradication of dracunculiasis. Since 1989 (when most endemic countries began reporting monthly from each endemic village), the number of new dracunculiasis cases has fallen from 892 055 in 12 endemic countries to 3190 in 4 countries in 2009, a decrease of more than 99%. The World Health Organization (WHO) recommends five public-health strategies for the prevention and control of NTDs: preventive chemotherapy; intensified case-management; vector control; the provision of safe water, sanitation and hygiene; and veterinary public health (that is, applying veterinary sciences to ensure the health and well-being of humans). Although one approach and delivered locally. - p. vii
  plos negl trop dis impact factor: Blue Marble Health Peter J. Hotez, 2016-09 Why do diseases of poverty afflict more people in wealthy countries than in the developing world? In 2011, Dr. Peter J. Hotez relocated to Houston to launch Baylor’s National School of Tropical Medicine. He was shocked to discover that a number of neglected diseases often associated with developing countries were widespread in impoverished Texas communities. Despite the United States’ economic prowess and first-world status, an estimated 12 million Americans living at the poverty level currently suffer from at least one neglected tropical disease, or NTD. Hotez concluded that the world’s neglected diseases—which include tuberculosis, hookworm infection, lymphatic filariasis, Chagas disease, and leishmaniasis—are born first and foremost of extreme poverty. In this book, Hotez describes a new global paradigm known as “blue marble health,” through which he asserts that poor people living in wealthy countries account for most of the world’s poverty-related illness. He explores the current state of neglected diseases in such disparate countries as Mexico, South Korea, Argentina, Australia, the United States, Japan, and Nigeria. By crafting public policy and relying on global partnerships to control or eliminate some of the world’s worst poverty-related illnesses, Hotez believes, it is possible to eliminate life-threatening disease while at the same time creating unprecedented opportunities for science and diplomacy. Clear, compassionate, and timely, Blue Marble Health is a must-read for leaders in global health, tropical medicine, and international development, along with anyone committed to helping the millions of people who are caught in the desperate cycle of poverty and disease.
  plos negl trop dis impact factor: Buruli Ulcer Gerd Pluschke, Katharina Röltgen, 2019-04-29 A major objective of this open access book is to summarize the current status of Buruli Ulcer (BU) research for the first time. It will identify gaps in our knowledge, stimulate research and support control of the disease by providing insight into approaches for surveillance, diagnosis, and treatment of Buruli Ulcer. Book chapters will cover the history, epidemiology diagnosis, treatment and disease burden of BU and provide insight into the microbiology, genomics, transmission and virulence of Mycobacterium ulcerans.
  plos negl trop dis impact factor: The Other America Michael Harrington, 1997-08 Examines the economic underworld of migrant farm workers, the aged, minority groups, and other economically underprivileged groups.
  plos negl trop dis impact factor: AIDS and the Historian Victoria Angela Harden, Guenter B. Risse, 1991
  plos negl trop dis impact factor: The Global Burden of Disease Christopher J. L. Murray, Alan D. Lopez, 1996 The Global Burden of Disease (GBD) provides systematic epidemiological estimates for an unprecedented 150 major health conditions. The GBD provides indispensable global and regional data for health planning, research, and education.
  plos negl trop dis impact factor: Skin-Related Neglected Tropical Diseases (Skin-NTDs): A New Challenge Roderick J. Hay, Kingsley Asiedu, 2019-07-31 This book is a printed edition of the Special Issue Skin-Related Neglected Tropical Diseases (Skin-NTDs)—A New Challenge that was published in TropicalMed
  plos negl trop dis impact factor: Dengue World Health Organization, 2009 This publication is intended to contribute to prevention and control of the morbidity and mortality associated with dengue and to serve as an authoritative reference source for health workers and researchers. These guidelines are not intended to replace national guidelines but to assist in the development of national or regional guidelines. They are expected to remain valid for five years (until 2014), although developments in research could change their validity.--Publisher's description.
  plos negl trop dis impact factor: Neglected Tropical Diseases - South Asia Sunit K. Singh, 2018-03-19 This book covers all aspects of Neglected Tropical Diseases in the region of South Asia. NTDs constitute a significant part of the total disease burden in this geographic area, including soil borne helminth infections, vector borne viral infections, protozoan infections and a few bacterial infections. The current volume covers the most common neglected viral, bacterial and protozoan infections. On top of that, the last part of the volume is dedicated to the management of neglected tropical diseases.
  plos negl trop dis impact factor: Neglected Tropical Diseases - Sub-Saharan Africa John Gyapong, Boakye Boatin, 2016-01-13 This book provides an overview on the major neglected tropical diseases (NTDs) occurring in Sub-Saharan Africa, such as Leishmaniasis, Buruli Ulcer and Schistosomiasis. In well-structured chapters epidemiology and biology of these parasitic diseases will be discussed in detail. Further, diagnostics and therapeutic approaches as well as prevention strategies will be reviewed. The book will be of interest to basic researchers and clinicians engaged in infectious disease, tropical medicine, and parasitology, and a must-have for scientists specialized in the characteristics of the Sub-Saharan region.
  plos negl trop dis impact factor: Neglected Tropical Diseases and Conditions of the Nervous System Marina Bentivoglio, Esper A. Cavalheiro, Krister Kristensson, Nilesh B. Patel, 2014-05-30 A number of diseases and conditions that occur primarily in remote rural or poor urban areas of low-income countries have traditionally been neglected by the neuroscience research community. These diseases and conditions affect the nervous system directly (sometimes with lethal consequences) and/or are associated with severe neurological sequels such as epilepsy, cognitive deficits, and sleep disruption. Several diseases also have the effect of promoting poverty by leaving sufferers unable to lead economically productive lives due to cognitive and behavioral disturbances or severe stigmatization. The pathogenesis of neural dysfunction in the diseases addressed in this book and their sequels remains unclear. Neuroscience of Neglected Diseases and Conditions makes available much needed information about how these diseases affect the human nervous system as well as to promote interest in further research. Further research into neglected diseases and conditions will uncover information that sheds light on more general topics of interest to the neuroscience research community.​
  plos negl trop dis impact factor: Disease and Mortality in Sub-Saharan Africa Dean T. Jamison, 2006-01-01 Current data and trends in morbidity and mortality for the sub-Saharan Region as presented in this new edition reflect the heavy toll that HIV/AIDS has had on health indicators, leading to either a stalling or reversal of the gains made, not just for communicable disorders, but for cancers, as well as mental and neurological disorders.
  plos negl trop dis impact factor: Trachoma Control World Health Organization, 2006-01-01 Trachoma is an infectious eye disease that causes blindness; it is prevalent in many poor rural communities. The World Health Organization has set the year 2020 as the target for global elimination of trachoma as a public health problem. To reach this target, the SAFE strategy (Surgery for trichiasis Antibiotics to treat Chlamydia trachomatis infection, and Facial cleanliness and Environmental improvement to reduce transmission of C. trachomatis from one person to another) is recommended for districts and communities with endemic disease. This guide has been written for managers of national and district trachoma control programs. It sets out, step-by-step, what is needed to assess the magnitude and extent of the trachoma problem in the area and how to plan, implement, monitor, and evaluate a program to control, and ultimately eliminate trachoma. Templates for a number of forms recommended for use in a program can be found in the annex. To allow adaptation of the forms for use in a specific program, electronic versions are available on the CD-ROM that accompanies this guide. The CD-ROM also contains an antibiotic requirement estimator, a template budget and a generic evaluation manual. Two versions of this guide are available:The trainer s version includes the guide with a set of 30 slides and the CD-ROM. The learner's version contains the guide with the CD-ROM.
  plos negl trop dis impact factor: Emerging Concepts of Innate Immune Responses to Neglected Tropical Diseases Malcolm Scott Duthie, Yasuyuki Goto, 2021-11-03
  plos negl trop dis impact factor: Preventive Chemotherapy in Human Helminthiasis World Health Organization, 2006 This manual focuses on how and when a set of low-cost or free drugs should be used in developing countries to control a set of diseases caused by worm infections. Preventive chemotherapy in this context means using drugs that are effective against a broad range of worm infections to simultaneously treat the four most common diseases caused by worms: river blindness (onchocerciasis), elephantiasis (lymphatic filariasis), schistosomiasis, and soil-transmitted helminthiasis. Significant opportunities also exist to integrate these efforts with the prevention and control of diseases such as trachoma. The new approach provides a critical first step in combining treatment regimens for diseases which, although different in themselves, require common resources and delivery strategies for control or elimination.
  plos negl trop dis impact factor: The Art and Politics of Science Harold Varmus, 2010-05-24 A Nobel Prize–winning cancer biologist, leader of major scientific institutions, and scientific adviser to President Obama reflects on his remarkable career. A PhD candidate in English literature at Harvard University, Harold Varmus discovered he was drawn instead to medicine and eventually found himself at the forefront of cancer research at the University of California, San Francisco. In this “timely memoir of a remarkable career” (American Scientist), Varmus considers a life’s work that thus far includes not only the groundbreaking research that won him a Nobel Prize but also six years as the director of the National Institutes of Health; his current position as the president of the Memorial Sloan-Kettering Cancer Center; and his important, continuing work as scientific adviser to President Obama. From this truly unique perspective, Varmus shares his experiences from the trenches of politicized battlegrounds ranging from budget fights to stem cell research, global health to science publishing.
  plos negl trop dis impact factor: Biodiversity and Health in the Face of Climate Change Melissa R. Marselle, Jutta Stadler, Horst Korn, Katherine N. Irvine, Aletta Bonn, 2019-06-11 This open access book identifies and discusses biodiversity’s contribution to physical, mental and spiritual health and wellbeing. Furthermore, the book identifies the implications of this relationship for nature conservation, public health, landscape architecture and urban planning – and considers the opportunities of nature-based solutions for climate change adaptation. This transdisciplinary book will attract a wide audience interested in biodiversity, ecology, resource management, public health, psychology, urban planning, and landscape architecture. The emphasis is on multiple human health benefits from biodiversity - in particular with respect to the increasing challenge of climate change. This makes the book unique to other books that focus either on biodiversity and physical health or natural environments and mental wellbeing. The book is written as a definitive ‘go-to’ book for those who are new to the field of biodiversity and health.
  plos negl trop dis impact factor: Rising Stars in Comparative and Clinical Medicine: 2021 Fazul Nabi, Muhammad Asif Arain, 2023-06-16
  plos negl trop dis impact factor: Forgotten People, Forgotten Diseases Peter J. Hotez, 2021-10-12 The neglected tropical diseases (NTDs) are among the most common infections of the world’s poorest people and have profound ramifications on affected populations, including physical, mental, social, and economic. This third edition of Forgotten People, Forgotten Diseases coincides with the third decade of the NTDs movement, which has given access to essential NTD preventative treatments and medications to more than 1 billion people. Professor Peter Hotez, MD, PhD, one of the founders of the NTD movement, discusses how the NTD space evolved and control was implemented against these ancient scourges, through alliances between nongovernmental development organizations and private-public partnerships. Forgotten People, Forgotten Diseases also Reports on the health and economic effects of the NTDs, and the challenges of measuring diseases that do not always kill, but adversely affect productivity, child development, pregnancy outcome, and economic development. Lays a roadmap for continued control of existing and newly identified NTDs and spotlights potential opportunities for reducing global poverty and “repairing the world.” Describes a global initiative to provide annual mass drug administration for more than one billion people affected by NTDs. Highlights the role of innovation and product development partnerships for new treatments and vaccines. Explains how science and vaccine diplomacy ensure that a new generation of biotechnologies reaches the world’s poorest people. Forgotten People, Forgotten Diseases remains an essential resource for anyone seeking insight into global advocacy coordination and mobilization of resources to combat NTDs and continues to tell the story of the world’s people who live in extreme poverty and what it means for them to live with these devastating diseases. “Like Dr. Hotez, I have struggled with how to best get the word out about our need to address NTDs and their link to poverty. Now he has provided us all with a remarkable tool, a book for people without an extensive scientific or medical background. Forgotten People, Forgotten Diseases is an excellent ‘one-stop’ primer about NTDs.”—Soledad O’Brien, Host, Matter of Fact with Soledad O’Brien
  plos negl trop dis impact factor: Neglected Tropical Diseases - Sub-Saharan Africa John O. Gyapong,
  plos negl trop dis impact factor: Evidence-Based Critical Care Robert C. Hyzy, 2017-05-30 This book provides learners with a unique opportunity by virtue of the format outlined above. Each case presentation has a case vignette, which leads up to an important clinical question, and is followed by additional discussion which resolves the question posed. This is a new way to present knowledge in a medical book and should help critical care practitioners, fellows, residents, allied health professionals and students expand their critical care knowledge in an efficient and effective manner. This approach should also benefit those preparing for board examinations.
  plos negl trop dis impact factor: International Encyclopedia of Public Health William C Cockerham, 2016-10-06 International Encyclopedia of Public Health, Second Edition, Seven Volume Set is an authoritative and comprehensive guide to the major issues, challenges, methods, and approaches of global public health. Taking a multidisciplinary approach, this new edition combines complementary scientific fields of inquiry, linking biomedical research with the social and life sciences to address the three major themes of public health research, disease, health processes, and disciplines. This book helps readers solve real-world problems in global and local health through a multidisciplinary and comprehensive approach. Covering all dimensions of the field, from the details of specific diseases, to the organization of social insurance agencies, the articles included cover the fundamental research areas of health promotion, economics, and epidemiology, as well as specific diseases, such as cancer, cardiovascular diseases, diabetes, and reproductive health. Additional articles on the history of public health, global issues, research priorities, and health and human rights make this work an indispensable resource for students, health researchers, and practitioners alike. Provides the most comprehensive, high-level, internationally focused reference work available on public health Presents an invaluable resource for both researchers familiar with the field and non-experts requiring easy-to-find, relevant, global information and a greater understanding of the wider issues Contains interdisciplinary coverage across all aspects of public health Incorporates biomedical and health social science issues and perspectives Includes an international focus with contributions from global domain experts, providing a complete picture of public health issues
  plos negl trop dis impact factor: Emerging Infectious Diseases , 2017
  plos negl trop dis impact factor: McKee's Pathology of the Skin, 2 Volume Set E-Book J. Eduardo Calonje, Thomas Brenn, Alexander J Lazar, Steven D. Billings, 2018-10-29 Comprehensive and lavishly illustrated, McKee's Pathology of the Skin, 5th Edition, is your reference of choice for up-to-date, authoritative information on dermatopathology. You'll find clinical guidance from internationally renowned experts along with details on etiology, pathogenesis, histopathology, and differential diagnosis – making this unique reference unparalleled in its wealth of clinical and histopathological material. The 5th Edition of this classic text is a must-have resource for practicing dermatopathologists and general pathologists who sign out skin biopsies. - Covers pathological aspects of skin diseases in addition to providing superb descriptions and illustrations of their clinical manifestations – the only available reference with this unique combination of features. - Integrates dermatopathology, clinical correlations, and clinical photographs throughout, and features bulleted lists of clinical features and differential diagnosis tables for easy reference. - Contains more than 5,000 superb histopathologic and clinical illustrations that demonstrate the range of histologic manifestations. - Brings you fully up to date with key molecular aspects of disease, the capabilities and limitations of molecular diagnostics, and targeted/personalized medicine. - Features up-to-date information on biologics, drug eruptions, and other developments in therapeutics. - Helps you stay current with the latest diagnostic tumor markers and other new developments in immunohistochemistry. - Includes a completely revised chapter on cutaneous lymphoma that reflects recent WHO-EORTC classification changes, as well as new coverage of sentinel lymph node biopsy for melanoma. - Shares the knowledge of the main editor Dr. J. Eduardo Calonje, along with co-editors Thomas Brenn, and Alexander Lazar, and new co-editor Steven D. Billings who offers expertise on both dermatopathology and soft tissue tumors. - Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.
  plos negl trop dis impact factor: Single-Domain Antibodies: Biology, Engineering and Emerging Applications Kevin A. Henry, C. Roger MacKenzie, 2018-03-19 Single-domain antibodies (sdAbs) represent the minimal antigen binding-competent form of the immunoglobulin domain and have unique properties and applications. SdAbs are naturally produced as the variable domains of the heavy chain-only antibodies of camelid ruminants and cartilaginous fishes, but can also be engineered synthetically from autonomous human or mouse VH or VL domains. The scope of this research topic and associated e-book covers current understanding and new developments in (i) the biology, immunology and immunogenetics of sdAbs in camelids and cartilaginous fishes, (ii) strategies for sdAb discovery, (iii) protein engineering approaches to increase the solubility, stability and antigen-binding affinity of sdAbs and (iv) specialized applications of sdAbs in areas such diagnostics, imaging and therapeutics.
  plos negl trop dis impact factor: Viral Infections of Humans Richard A. Kaslow, Lawrence R. Stanberry, James W. Le Duc, 2014-09-27 Striking changes have occurred in the world since the publication of the last edition of Viral Infections of Humans. The global population is rapidly approaching 8 billion; climate change is leading to the introduction of new hosts, vectors and virus diseases heretofore never seen in many parts of the world; technological advances have revolutionized the ability to recognize and characterize viruses new and old; vaccines are altering the epidemiological landscape of the diseases they target, in some cases raising the hope of their eradication and remarkably powerful computational tools are enabling not only detection of outbreaks of disease much sooner than in the past but also, through complex mathematical modeling, more accurate prediction of their potential impact. The new Fifth Edition of Viral Infections of Humans captures the both the excitement and frustration of the dynamic struggle between humankind and the viruses that continue to cause immense suffering. It presents the latest concepts, methods and technologies in epidemiology, detection, investigation, modeling and intervention. Updated and entirely new chapters by dozens of experts across the field provide analytic summaries of current knowledge of viruses and prions causing acute syndromes, chronic illnesses and/or malignancies. In sum, this ambitiously expanded volume offers a uniquely comprehensive perspective on viruses in humans, from agents of classic diseases (e.g., hepatitis, measles, polio, rabies and yellow fever), to those with greatest pandemic impact (e.g., influenza and human immunodeficiency virus), to those discovered relatively recently (e.g., henipavirus, metapneumovirus and norovirus). The new Fifth Edition of Viral Infections of Humans is an invaluable reference for students, fellows and established professionals in the fields of microbiology, public health and infectious disease epidemiology, medicine and health policy.
  plos negl trop dis impact factor: Feigin and Cherry's Textbook of Pediatric Infectious Diseases E-Book James Cherry, Gail J. Demmler-Harrison, Sheldon L. Kaplan, William Steinbach, Peter J Hotez, 2017-12-29 Offering unparalleled coverage of infectious diseases in children and adolescents, Feigin & Cherry's Textbook of Pediatric Infectious Diseases 8th Edition, continues to provide the information you need on epidemiology, public health, preventive medicine, clinical manifestations, diagnosis, treatment, and much more. This extensively revised edition by Drs. James Cherry, Gail J. Demmler-Harrison, Sheldon L. Kaplan, William J. Steinbach, and Peter J. Hotez, offers a brand-new full-color design, new color images, new guidelines, and new content, reflecting today's more aggressive infectious and resistant strains as well as emerging and re-emerging diseases - Discusses infectious diseases according to organ system, as well as individually by microorganisms, placing emphasis on the clinical manifestations that may be related to the organism causing the disease. - Provides detailed information regarding the best means to establish a diagnosis, explicit recommendations for therapy, and the most appropriate uses of diagnostic imaging. - Features expanded information on infections in the compromised host; immunomodulating agents and their potential use in the treatment of infectious diseases; and Ebola virus. - Contains hundreds of new color images throughout, as well as new guidelines, new resistance epidemiology, and new Global Health Milestones. - Includes new chapters on Zika virus and Guillain-Barré syndrome. - Expert ConsultTM eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices.
  plos negl trop dis impact factor: Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant,E-Book Yvonne Maldonado, Victor Nizet, Elizabeth D. Barnett, Kathryn M. Edwards, Richard Malley, 2024-03-11 **Selected for Doody's Core Titles® 2024 in Infectious Disease**A must-have reference for all clinicians who need comprehensive, in-depth advice and recommendations in this complex field, Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant, 9th Edition, provides expert coverage from the world's leading authorities in immunology and infectious diseases. It offers the most up-to-date and complete guidance on infections found in utero, during delivery, and in the neonatal period in both premature and term infants—indispensable information for all clinicians who are involved in the care and well-being of these vulnerable patient populations. Three new associate editors and many new contributing authors bring new insight and a fresh perspective throughout the text. - Provides a detailed summation of existing information on fetal and neonatal infections, ideal for all clinicians who encounter infections for which they need additional background and guidance on the best approach. - Helps you form a definitive diagnosis and create optimal treatment plans using evidence-based recommendations and expert guidance from world authorities. - Contains two new chapters on SARS-CoV-2 and Zika, plus thorough updates throughout the volume that incorporate new knowledge and current practice in this fast-changing field. - Reorganizes existing chapters to provide more in-depth discussions on bacterial sepsis, meningitis, pneumocystis, and less common fungal infections. - Covers all recent major advances in both biology and medicine that have contributed greatly to our understanding of infections that affect the fetus and newborn. - Gives special attention to the prevention and treatment of diseases found in developing countries as well as the latest findings about new antimicrobial agents, Gram-negative infections and their management, and recommendations for immunizations in pregnancy. - Uses a consistent, reader-friendly format that features a full-color design with hundreds of illustrations, photographs, diagrams radiographic images, and drawings. - Includes sequelae of infections that affect older children and adults; infection in the adult is described whenever pertinent to recognition of infection during pregnancy, which may affect the developing fetus and newborn infant. - Any additional digital ancillary content may publish up to 6 weeks following the publication date.
  plos negl trop dis impact factor: The Mononuclear Phagocyte System in Infectious Disease Geanncarlo Lugo-Villarino, Céline Cougoule, Etienne Meunier, Yoann Rombouts, Christel Vérollet, Luciana Balboa, 2019-10-04 The Mononuclear Phagocyte System (MPS) of vertebrates is composed of monocytes, macrophages and dendritic cells. Together, they form part of the first line of immune defense against a variety of pathogens (bacteria, fungi, parasites and viruses), and thus play an important role in maintaining organism homeostasis. The mode of transmission, type of replication and mechanism of disease-causing differ significantly for each pathogen, eliciting a unique immune response in the host. Within this context, the MPS acts as both the sentinel and tailor of the immune system. As sentinels, MPS cells are found in blood and within tissues throughout the body to patrol against pathogenic insult. The strategy to detect 'microbial non-self' relies on MPS to recognize conserved microbial products known as 'pathogen-associated molecular pattern' (PAMPs). PAMPs recognition represents a checkpoint in the response to pathogens and relies on conserved 'pattern recognition receptors' (PRRs). Upon PRR engagement, MPS mount a cell-autonomous attack that includes the internalization and compartmentalization of intracellular pathogens into toxic compartments that promote destruction. In parallel, MPS cells launch an inflammatory response composed of a cellular arm and soluble factors to control extracellular pathogens. In cases when innate immunity fails to eliminate the invading microbe, MPS serves as a tailor to generate adaptive immunity for pathogen eradication and generation of memory cells, thus ensuring enhanced protection against re-infection. Indeed, MPS cell functions comprise the capture, process, migration and delivery of antigenic information to lymphoid organs, where type-1 immunity is tailored against intracellular microbes and type-2 immunity against extracellular pathogens. However, this potent adaptive immunity is also a double-edge sword that can cause aberrant inflammatory disorders, like autoimmunity or chronic inflammation. For this reason, MPS also tailors tolerance immunity against unwanted inflammation. Successful clearance of the microbe results in its destruction and proper collection of debris, resolution of inflammation and tissue healing for which MPS is essential. Reciprocally, as part of the evolutionary process taking place in all organisms, microbes evolved strategies to circumvent the actions bestowed by MPS cells. Multiple pathogens modulate the differentiation, maturation and activation programs of the MPS, as an efficient strategy to avoid a dedicated immune response. Among the most common evasion strategies are the subversion of phagocytosis, inhibition of PRR-mediated immunity, resistance to intracellular killing by reactive oxygen and nitrogen species, restriction of phagosome maturation, modulation of cellular metabolism and nutrient acquisition, regulation of cell death and autophagy, and modulation of pro-inflammatory responses and hijacking of tolerance mechanisms, among others. The tenet of this eBook is that a better understanding of MPS in infection will yield insights for development of therapeutics to enhance antimicrobial processes or dampen detrimental inflammation for the host's benefit. We believe that contributions to this topic will serve as a platform for discussion and debate about relevant issues and themes in this field. Our aim is to bring expert junior and senior scientists to address recent progress, highlight critical knowledge gaps, foment scientific exchange, and establish conceptual frameworks for future MPS investigation in the context of infectious disease.
  plos negl trop dis impact factor: Proceedings of the 1st International Conference for Health Research – BRIN (ICHR 2022) Ika Nurlaila, Yunefit Ulfa, Hayani Anastasia, Gurendro Putro, Rika Rachmalina, Rozana Ika Agustiya, Novaria Sari Dewi Panjaitan, Rosantia Sarassari, Anna Lystia Poetranto, Sela Septima Mariya, 2023-04-02 This is an open access book. The National Research and Innovation Agency (Acronymized in Bahasa as BRIN, Badan Riset and Inovasi Nasional), the Republic of Indonesia was launched in 2021 and has been the only one of Indonesia authorized research institution since. The Agency embodies throughout department and non-department research bodies in Indonesia and answers and thus responsible directly to the President of Indonesia. Despite its juvenile age, BRIN is in a tight competition with urgencies of untangling unresolved issues in various aspects in collective life as a nation and a state spanning socioeconomic and culture to medicine and its translational derivatives. To function as effectively as expected, BRIN has launched 12 research organizations with each is accountable for a specific research field as reflected by the expertise of the pertinent researchers. Among those, Research Organization for Health was established as an answer to the major challenge of overcoming national burdens which are holistically captured as the roadmaps of SDG’s Indonesia where Health stands specially as the top three priority and regarded as Good Health-Wellbeing. It is clear that what have been produced through long chain of processes in the research chambers must be driven forward and translated accordingly to reach downstream utilizations in such a way that the good health and well-being are reachable in any levels. As to manifesting these goals into realization, knowledge sharing is deemed to be a plausible vehicle. This enables disseminations of most current research projects related to health across research institution, regionally or globally. Therefore, we see the need to organize our very first international conference that is, further, set as one of our annual events with contemporary umbrella themes. We welcome researchers, scholars, and practitioners in health and health-related fields to share their insightful research results in our conference. The general objective of BRIN’s 1st International Conference for Health (ICHR) is to facilitate dissemination and exchange of most recent progresses made across research institutions and to promote prospectus multi-nationals and or multi-institutional collaborations to achieve the good-health and well-being.
  plos negl trop dis impact factor: Tropical Diseases Bulletin , 1958
  plos negl trop dis impact factor: Vaccines E-Book Walter A. Orenstein, Paul A. Offit, Kathryn M. Edwards, Stanley A. Plotkin, 2017-04-07 From the development of each vaccine to its use in reducing disease, Plotkin's Vaccines, 7th Edition, provides the expert information you need to provide optimal care to your patients. This award-winning text offers a complete understanding of each disease, as well as the latest knowledge of both existing vaccines and those currently in research and development. Described by Bill Gates as an indispensable guide to the enhancement of the well-being of our world, Plotkin's Vaccines is a must-have reference for current, authoritative information in this fast-moving field. - Includes complete information for each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, epidemiology, and public health and regulatory issues – plus complete information for each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies. - Analyzes the cost-benefit and cost-effectiveness of different vaccine options. - Helps you clearly visualize concepts and objective data through an abundance of tables and figures. - Covers the new oral cholera and zoster vaccines, as well as newly licensed meningococcal group B vaccines and a newly licensed dengue vaccine. - Brings you up to date on successful human trials of Ebola vaccines, an enterovirus 71 vaccine licensed in China, and new recommendations and changes to polio vaccines. - Features a new chapter on maternal immunization. - Expert ConsultTM eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices.
  plos negl trop dis impact factor: Zoonoses: Infections Affecting Humans and Animals Andreas Sing, 2023-10-09 This second fully revised and extended edition of “Zoonoses - Infections Affecting Humans and Animals” covers the most important pathogens impacting both human and animal public health and debates current developments in this interdisciplinary field from a One Health perspective. Following a setting approach, the individual chapters each review zoonoses occurring in a specific group of animals, such as production animals, pets or wildlife, or in a defined ecosystem. A focus is put on zoonoses emerging along the food chain and on antibiotic resistance as an increasing challenge in infectious disease management. Special interest chapters debate non-resolved and currently hotly debated zoonoses, foremost COVID-19, influenza, Crohn/paratuberculosis and chronic botulism, also taking into account the economic and ecological aspects of zoonotic disease outbreaks. This second edition includes brand-new chapters on emerging pathogens such as SARS-CoV-2, chlamydia and helminths, it reviews historic zoonoses, provides additional insights into pathogens of reptiles and highlights significant neglected tropical diseases. This reference work is a must-read for researchers, health professionals and students in Microbiology and Veterinary Medicine. The book’s ambition to spread knowledge on zoonoses and on strategies on how to tackle them complies with the United Nations Sustainable Goals, in particular Goal 3 – Good Health and Well-Being.
  plos negl trop dis impact factor: Non-invasive diagnostic tools in the management of skin disorders Elisa Zavattaro, Paola Savoia, Federica Veronese, 2023-10-03
  plos negl trop dis impact factor: History of Arbovirology: Memories from the Field Nikos Vasilakis, Laura D. Kramer, 2023-05-08 These books bring together a panel of expert arbovirologists who recall the history of arbovirology from very personal perspectives. In these timely volumes, the authors describe seminal moments in their experiences in the field and how they integrated these findings with lab studies to further clarify the ecology and epidemiology of diverse arboviruses. Authors identify the most pressing questions that remain to be answered, providing a basis for current research and a stimulus to engage those entering the field. Over the last 20 years a generational gap has developed between the giants of arbovirus research and discovery and the new generation. This gap developed due to an ebbing of training and investment in passing the scepter to the next generation, leading to a lack of continuity among the generations that threatens to derail the rich history of virus discovery, field epidemiology and understanding of the richness of diversity that surrounds us. This lack of continuity may have immediate and disastrous consequences for public health when yet to be discovered arboviruses emerge. The purpose of these books is to bridge this gap by providing a historical context for the work being done today and provide continuity between the generations. To this end, the books provide a narrative of the thrill of scientific discovery and excitement of field adventures and lab studies of that generation -- essential reading for every arbovirologist, and highly recommended for all virologists and public health officials, as well as those students considering future research options. Volume I consists of the personal reflections of arbovirologists who played a significant role in the advancement of arbovirology across the globe. Volume II transitions to descriptions of region-specific and virus family-specific perspectives of arbovirology, as well as recollections of the early events of molecular advances and pathogenesis studies. Volume I presents personal reflections from arbovirologists key to the understanding and advancement of this field Offers a comprehensive historical analysis of arbovirology by crucial contributors to this field First-hand narratives of seminal studies and experiments, illuminating how these have contributed to current knowledge
  plos negl trop dis impact factor: Emerging zoonoses and transboundary infections Yashpal S. Malik, Lester J. Perez, Levon Abrahamyan, 2023-03-03
  plos negl trop dis impact factor: Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant Christopher B. Wilson, Victor Nizet, Yvonne Maldonado, Jack S. Remington, Jerome O. Klein, 2015-03-16 Infectious Diseases of the Fetus and Newborn Infant, written and edited by Drs. Remington, Klein, Wilson, Nizet, and Maldonado, remains the definitive source of information in this field. The 8th edition of this authoritative reference provides the most up-to-date and complete guidance on infections found in utero, during delivery, and in the neonatal period in both premature and term infants. Special attention is given to the prevention and treatment of these diseases found in developing countries as well as the latest findings about new antimicrobial agents, gram-negative infections and their management, and recommendations for immunization of the fetus/mother. Nationally and internationally recognized in immunology and infectious diseases, new associate editors Nizet and Maldonado bring new insight and fresh perspective to the book. Form a definitive diagnosis and create the best treatment plans possible using evidence-based recommendations and expert guidance from world authorities. Locate key content easily and identify clinical conditions quickly thanks to a consistent, highly user-friendly format now featuring a full-color design with hundreds of illustrations, and fresh perspectives from six new authoritative chapter lead authors. Explore what's changing in key areas such as: - emerging problems and concepts in maternal, fetal, and neonatal infectious diseases - anticipation and recognition of infections occurring in utero, during delivery, and in the neonatal period Stay on the cutting edge of your field with new and improved chapters including: obstetric factors associated with infections of the fetus and newborn infant; human milk; borella infections; tuberculosis; bordetella pertussis and other bordetella sp infections; herpes simplex; toxoplasmosis; pneumocystis and other less common fungal infections; and healthcare-associated infections in the nursery Keep up with the most relevant topics in fetal/neonatal infectious disease including new antimicrobial agents, gram- negative infections and their management, and recommendations for immunization of the fetus/mother. Overcome clinical challenges in developing countries where access to proper medical care is limited. Expert Consult eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, references, and videos from the book on a variety of devices.